Literature DB >> 9043564

Stability of meropenem in intravenous solutions.

P R Patel1, S E Cook.   

Abstract

The stability of meropenem in various i.v. fluids stored in various containers for i.v. use was studied. Solutions of meropenem were prepared in a variety of i.v. diluents in polyvinyl chloride (PVC) bags, glass vials, and commercial easy-to-prepare infusion systems. Solutions for storage in PVC bags were prepared with meropenem concentrations of 1 and 20 mg/mL; in glass vials, 2.5 and 50 mg/mL; and in commercial easy-to-prepare infusion systems, 2.5 and 20 mg/mL (Baxter Minibag Plus system) and 1, 5, and 20 mg/mL (ADD-Vantage system, Abbott). The solutions were stored for up to 48 hours at 4-5 or 21-26 degrees C. Meropenem concentrations were determined by high-performance liquid chromatography. The stability of meropenem was influenced by the drug concentration; the drug was stable for a longer time in the 1-mg/mL solution than in the 20- and 50-mg/mL solutions. Stability was also influenced by storage temperature; the drug was stable for a longer time in solutions stored at 4-5 degrees C than in solutions stored at 21-26 degrees C. Meropenem was stable for the longest time in sterile water for injection and in 0.9% sodium chloride injection. The stability of meropenem in solutions in PVC bags, glass vials, Baxter Minibag Plus containers, and ADD-Vantage bags was influenced by the i.v. fluid used to reconstitute the drug, the concentration of the final solution, and the storage temperature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043564     DOI: 10.1093/ajhp/54.4.412

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  9 in total

1.  In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem.

Authors:  Cristina Tomasello; Anna Leggieri; Roberta Cavalli; Giovanni Di Perri; Antonio D'Avolio
Journal:  Hosp Pharm       Date:  2015-04-08

2.  Short versus long infusion of meropenem in very-low-birth-weight neonates.

Authors:  Helgi Padari; Tuuli Metsvaht; Lenne-Triin Kõrgvee; Eva Germovsek; Mari-Liis Ilmoja; Karin Kipper; Koit Herodes; Joseph F Standing; Kersti Oselin; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

3.  Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.

Authors:  Sarah Fawaz; Stephen Barton; Laura Whitney; Julian Swinden; Shereen Nabhani-Gebara
Journal:  Hosp Pharm       Date:  2018-05-30

4.  Chemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer Solution.

Authors:  Pegah Shakeraneh; Risako Robinson; Wesley D Kufel; L Nathan Tumey; Samantha R Benjamin; Christopher D Miller; William Darko; Luke A Probst; Robert W Seabury
Journal:  Hosp Pharm       Date:  2020-01-23

5.  Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy.

Authors:  Julia Langgartner; Antje Vasold; Thomas Glück; Michel Reng; Frieder Kees
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

6.  Sustained Pulmonary Delivery of a Water-Soluble Antibiotic Without Encapsulating Carriers.

Authors:  Winston Ong; Pawel Nowak; Yen Cu; Lisa Schopf; James Bourassa; Elizabeth Enlow; Samuel M Moskowitz; Hongming Chen
Journal:  Pharm Res       Date:  2015-10-27       Impact factor: 4.200

7.  An investigation of the stability of meropenem in elastomeric infusion devices.

Authors:  Finbarr Foy; Giuseppe Luna; Jorge Martinez; Zach Nizich; Jason Seet; Katie Lie; Bruce Sunderland; Petra Czarniak
Journal:  Drug Des Devel Ther       Date:  2019-08-01       Impact factor: 4.162

8.  Suitability of Amoxicillin-Clavulanic Acid for Administration via Prolonged Infusion.

Authors:  Sarah Fawaz; Breanna Dixon; Stephen Barton; Amna Mohamed; Shereen Nabhani-Gebara
Journal:  Drug Des Devel Ther       Date:  2020-01-10       Impact factor: 4.162

9.  Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability.

Authors:  Laurens Manning; Cameron Wright; Paul R Ingram; Timothy J Whitmore; Christopher H Heath; Ingrid Manson; Madhu Page-Sharp; Sam Salman; John Dyer; Timothy M E Davis
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.